Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacological and genetic imaging of executive function deficits
NL-OMON31059Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of metyrosine in Autism Spectrum Disorder (ASD), schizophrenia and Velocardiofacial syndrome (VCFS) (4 cohorts), sponsored by Amsterdam University Medical Center. Planned start Oct 2007; status: not yet recruiting.
02
Drugs
metyrosine
03
Conditions
Autism Spectrum Disorder (ASD)schizophreniaVelocardiofacial syndrome (VCFS)
Beyond the preview
Go deeper on NL-OMON31059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31059.